Derick Munkombwe
Overview
Explore the profile of Derick Munkombwe including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
97
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chizimu J, Mudenda S, Yamba K, Lukwesa C, Chanda R, Nakazwe R, et al.
JAC Antimicrob Resist
. 2024 Oct;
6(5):dlae170.
PMID: 39464860
Background: The inappropriate use of antibiotics in hospitals contributes to the development and spread of antimicrobial resistance (AMR). This study evaluated the prevalence of antibiotic use and adherence to the...
2.
Kebotsamang T, Munkombwe D, Bwalya L, Kelly P, Kayamba V
Dig Dis
. 2024 Jan;
42(2):154-160.
PMID: 38185098
Introduction: Helicobacter pylori (H. pylori) is one of the most important infections globally, affecting more than 50% of the human population. Clarithromycin (CLA)-containing regimens are recommended for empirical eradication of...
3.
Ashiru-Oredope D, Nabiryo M, Zengeni L, Kamere N, Makotose A, Olaoye O, et al.
J Public Health Afr
. 2023 Aug;
14(6):2335.
PMID: 37538939
In recent years, health partnerships have shared infection prevention and control innovations between United Kingdom hospitals and Low-Middle-Income Countries. However, none had focused on antimicrobial stewardship (AMS), a core component...
4.
Kamere N, Rutter V, Munkombwe D, Aywak D, Muro E, Kaminyoghe F, et al.
Bull World Health Organ
. 2023 Jun;
101(6):403-411.
PMID: 37265674
Efficient and secure supply chains are vital for effective health services worldwide. In low- and middle-income countries, the accessibility, affordability and availability of essential medicines, including antimicrobials, remain challenging. Ineffective...
5.
Chikondowa P, Munkombwe D, Chikwambi Z, Kuona P, Masimirembwa C
Pharmacogenomics
. 2023 May;
24(8):449-457.
PMID: 37248698
6-mercaptopurine usage is associated with myelotoxicity and increased risk in patients carrying metabolism-related genetic variations. This study aimed to determine the frequency of candidate gene polymorphisms and their association with...
6.
Ikhile I, Gulpinar G, Iqbal A, Kamere N, Ward B, Halai M, et al.
J Pharm Policy Pract
. 2023 Mar;
16(1):33.
PMID: 36864477
Background: Antimicrobial resistance (AMR) is a global public health concern currently mitigated by antimicrobial stewardship (AMS). Pharmacists are strategically placed to lead AMS actions that contribute to responsible use of...
7.
Kamere N, Garwe S, Akinwotu O, Tuck C, Krockow E, Yadav S, et al.
Antibiotics (Basel)
. 2022 Sep;
11(9).
PMID: 36139929
Antimicrobial resistance (AMR) is a global health problem threatening safe, effective healthcare delivery in all countries and settings. The ability of microorganisms to become resistant to the effects of antimicrobials...
8.
Mukosha M, Zingani E, Kalungia A, Mwila C, Mwanza J, Mweetwa B, et al.
Int J Pharm Pract
. 2022 Jun;
30(4):360-366.
PMID: 35731635
Objectives: Low job satisfaction levels among pharmacists are associated with poor motivation and performance in the workplace. However, in Zambia, the job satisfaction levels of pharmacists remain unknown. Therefore, the...
9.
Chabala F, Siew E, Mutale W, Mulenga L, Mweemba A, Goma F, et al.
PLoS One
. 2021 Jul;
16(7):e0252768.
PMID: 34252117
Persons living with HIV (PLWH) receiving tenofovir disoproxil fumarate (TDF)-based antiretroviral therapy (ART) risk suffering TDF-associated nephrotoxicity (TDFAN). TDFAN can result in short- and long-term morbidity, including permanent loss of...
10.
Mufwambi W, Stingl J, Masimirembwa C, Manasa J, Nhachi C, Stadler N, et al.
Front Pharmacol
. 2021 Jan;
11:551522.
PMID: 33510634
Sub-Saharan Africa and other low- and middle-income countries (LMICs) have the highest rates of antimicrobial resistance (AMR) driven by high rates of antimicrobial utilization. This is a concern as AMR...